Status message

Active context: kki_bg_colors_yellow

Cholesterol in ASD II

Principal Investigator:

The purpose of this application is to allow for continued data cleaning of the identifiable data collected under terminated study NA_00020928 (PI Tierney; IRB2), including receipt of data from the other study sites and, if applicable, data verification with identifiable source documents.

Bradley L. Schlaggar, M.D., Ph.D., Named President and CEO of Kennedy Krieger Institute

We’re thrilled to welcome Bradley L. Schlaggar, M.D., Ph.D., to the Kennedy Krieger family as our next President and CEO.
Learn more.


Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.